INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 454m ago
House PTR54m ago
SEC 13F53m ago
Robinhood Chain53m ago

Results

78,999 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Tax withholding
F$211K
49.5K sh
Mar 19, 2026Mar 20, 2026
Page 1304 of 1975
← PrevNext →
traded Mar 19, 2026
+1d
SEC Form 4

Evidence

12
DD
Duffy Kristine DDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,495
236 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

12
AH
Antonello Katherine H.Director, President & CEO
EIGEmployers Holdings, Inc.
Tax withholding
F$205K
5,258 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

12
BJ
Boone Travis JDirector, PRESIDENT & CEO
ORNOrion Group Holdings Inc
Tax withholding
F$109K
10.5K sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

12
RH
Robbins Edward Hutchinson Jr.EVP, General Counsel
TLSTELOS CORP
Tax withholding
F$216K
50.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

12
SJ
Stenberg JonDirector, President & CEO
CIACITIZENS, INC.
Tax withholding
F$55K
11.9K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

12
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,495
236 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

12
HB
Herraiz Lizette BenediGENERAL COUNSEL
STRAStrategic Education, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
2,982 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

12
DM
Dawsey James MDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$14K
453 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

11
DD
Dieter DavidEVP & General Counsel
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL$488K
14.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
YL
You Harry L.Director, 10% Owner
HQHorizon Quantum Holdings Ltd.
Grant or award
A—
1.16M sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
8,433 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
543.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
CC
Champlin Christopher CraigSenior Vice President, Sales
EIGEmployers Holdings, Inc.
Tax withholding
F$12K
306 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
9,167 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
NG
Nixon D. GailSenior VP, Human Resources
NNBRNN INC
Tax withholding
F$1,849
1,249 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
30.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
DS
dMY Squared Sponsor, LLCDirector, 10% Owner
DMYYdMY Squared Technology Group, Inc.
Derivative conversion
C—
1.16M sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
487.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
DS
dMY Squared Sponsor, LLCDirector, 10% Owner
DMYYdMY Squared Technology Group, Inc.
Derivative conversion
C—
1.16M sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
100.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
211.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SA
Shlimak AnnaSee Remarks
CRONCronos Group Inc.
Tax withholding
F$25K
9,767 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
162.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
211.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
MT
Marcus Andrew T.See Remarks
VACMARRIOTT VACATIONS WORLDWIDE Corp
Grant or award
A—
14.6K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
22.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
MM
Mutschink John M.EVP, Chief Admin Officer
EIGEmployers Holdings, Inc.
Tax withholding
F$25K
635 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
100.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
22.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
BH
Brown HaydenDirector, President & CEO
UPWKUPWORK, INC
Option exercise
M—
17.7K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
40.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
60.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence